Skip to main content
Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

More about this publication?
Volume 13, Number 2, 2007

Articles

Favourites:
ADD

Design of Second Generation HIV-1 Integrase Inhibitors
pp. 129-141(13)
Authors: Deng, Jinxia; Dayam, Raveendra; Al-Mawsawi, Laith Q.; Neamati, Nouri

Favourites:
ADD

HIV Entry Inhibitors Targeting gp41: From Polypeptides to Small-Molecule Compounds
pp. 143-162(20)
Authors: Liu, Shuwen; Wu, Shuguang; Jiang, Shibo

Favourites:
ADD

Chemokines and Defensins as HIV Suppressive Factors: An Evolving Story
pp. 163-172(10)
Author: Garzino-Demo, Alfredo

Favourites:
ADD

Carbohydrate Microarrays as Tools in HIV Glycobiology
pp. 173-183(11)
Authors: Ratner, Daniel M.; Seeberger, Peter H.

Favourites:
ADD

Defining Carbohydrate Antigens as HIV Vaccine Candidates
pp. 185-201(17)
Authors: Pashov, Anastas; Perry, Marty; Dyar, Michael; Chow, Marie; Kieber-Emmons, Thomas

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Atenolol: Differences in Mode of Action Compared with other Antihypertensives.An Opportunity to Identify Features that Influence Outcome?
pp. 229-239(11)
Authors: Karagiannis, Asterios; Mikhailidis, Dimitri P.; Kakafika, Anna I.; Tziomalos, Konstantinos; Athyros, Vasilios G.

Favourites:
ADD

Pharmacogenetics and Drug Therapy in Psychiatry - The Role of the CYP2D6 Polymorphism
pp. 241-250(10)
Authors: Vandel, P.; Talon, J. M.; Haffen, E.; Sechter, D.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content